Evidence map›Paper›PMID 40347107›Full record

ArticleNucleic acids research2025

PLIP 2025: introducing protein-protein interactions to the protein-ligand interaction profiler.

Philipp Schake, Sarah Naomi Bolz, Katja Linnemann, Michael Schroeder

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 134 papers.

0numbers the graph read from it
0cells of the map it votes in
134citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

134 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Characterization of a CYP107 family vitamin DArchives of biochemistry and biophysics · 2026
    Article
  7. RSC advances · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

74 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Philipp SchakeBiotec and scads.ai, TU Dresden, 01307 Dresden, Germany.
Sarah Naomi BolzBiotec and scads.ai, TU Dresden, 01307 Dresden, Germany.
Katja LinnemannBiotec and scads.ai, TU Dresden, 01307 Dresden, Germany.
Michael SchroederBiotec and scads.ai, TU Dresden, 01307 Dresden, Germany.ORCID 0000-0003-2848-6949

Funding

Bundesministerium für Bildung und ForschungTU Dresden
6 · The paper itself

Abstract

PLIP, the protein-ligand interaction profiler, analyses molecular interactions in protein structures. PLIP detects eight types of non-covalent interactions. Initially focused on small-molecule, DNA, and RNA interactions to a protein, the current release incorporates protein-protein interactions. We document the usefulness of this feature by comparing PLIP interactions of the cancer drug venetoclax with the native protein-protein interaction of Bcl-2 and BAX. PLIP reveals how the drug mimics the native interaction, as there is critical overlap in the interaction profiles. PLIP is available as a web server, source code with containers, and Jupyter notebook. The PLIP web server is online at https://plip-tool.biotec.tu-dresden.de.

Indexed as

Protein Interaction MappingSoftwarebcl-2-Associated X ProteinBridged Bicyclo Compounds, HeterocyclicHumansInternetLigandsProtein BindingProto-Oncogene Proteins c-bcl-2Sulfonamidesbcl-2-Associated X ProteinBCL2 protein, humanBridged Bicyclo Compounds, HeterocyclicLigandsProto-Oncogene Proteins c-bcl-2Sulfonamidesvenetoclax

Identifiers

PMID40347107
PMCPMC12230730

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.